title: Antithrombotic therapy for cerebrovascular disorders. An update.
authors.forename: D G
authors.initials: DG
authors.lastname: Sherman
authors.forename: M L
authors.initials: ML
authors.lastname: Dyken
authors.forename: M
authors.initials: M
authors.lastname: Gent
authors.forename: J G
authors.initials: JG
authors.lastname: Harrison
authors.forename: R G
authors.initials: RG
authors.lastname: Hart
authors.forename: J P
authors.initials: JP
authors.lastname: Mohr
mesh_terms: D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors